Acute Bronchiolitis: The Less, the Better?
- Авторы: Virgili F.1, Nenna R.1, Di Mattia G.1, Matera L.1, Petrarca L.1, Conti M.G.1, Midulla F.1
-
Учреждения:
- Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
- Выпуск: Том 20, № 3 (2024)
- Страницы: 216-223
- Раздел: Medicine
- URL: https://medjrf.com/1573-3963/article/view/645534
- DOI: https://doi.org/10.2174/0115733963267129230919091338
- ID: 645534
Цитировать
Полный текст
Аннотация
Background:Acute bronchiolitis is a viral infection of the lower respiratory tract affect- ing infants aged under 12 months, variably presenting with respiratory distress, diffuse crackles and inflammatory wheezing. The main causative agent is Respiratory Syncytial Virus (RSV). The diagnosis is clinical and treatment mainly supportive. Despite the availability of more than 30 in- ternational guidelines, consistent management recommendations are lacking and considerable vari- ability in patients care persists among different providers.
Objective:To review and describe current knowledge about epidemiology, physiopathology, clin- ic, diagnosis and management of acute bronchiolitis, with particular emphasis on updated evidence and future perspectives in terms of treatment and prevention.
Methods and Results:We searched Cochrane for systematic reviews and PubMed for scientific ar- ticles published in the last 10 years, using a combination of the following search terms: "bronchi- olitis", "respiratory syncytial virus", "epidemiology", "risk factors", "severity", "diagnosis", "clin- ic", "diagnostic imaging", "management", "asthma", "wheezing", "bronchodilator", "steroids", "hypertonic saline", "oxygen", "blood gas analysis", "HHHFNC", "rehydration", "enteral feed- ing", "parenteral hydration", "prevention", "vaccine" and "COVID-19 or SARS-CoV2". We ac- cordingly performed a deep and extensive selection of the most updated and considerable litera- ture on the matter, summarizing the most significant evidence concerning all aspects of acute bron- chiolitis (epidemiology, clinic, diagnosis, management and prevention). Furthermore, we ex- amined references and available guidelines from UK, USA, Canada, Italy and Spain. Results are extensively discussed below.
Conclusion:Although acute bronchiolitis has been a widely known disease for decades, its thera- peutic approach remained unchanged and essentially limited to respiratory and metabolic support. Despite the abundance of studies, there is no significant evidence concerning therapeutic alterna- tives (e.g. steroids, inhaled hypertonic solution), which are therefore not recommended. Accord- ing to most recent data, "acute bronchiolitis" definition encompasses a plethora of different clini- cal entities related to each subjects genetic and immune predisposition. Therefore, future research should focus on the precise characterization of such subcategories in order to individualize thera- peutic management and ensure the most appropriate evidence-based care.
Ключевые слова
Об авторах
Fabrizio Virgili
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Автор, ответственный за переписку.
Email: info@benthamscience.net
Raffaella Nenna
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Email: info@benthamscience.net
Greta Di Mattia
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Email: info@benthamscience.net
Luigi Matera
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Email: info@benthamscience.net
Laura Petrarca
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Email: info@benthamscience.net
Maria Conti
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Email: info@benthamscience.net
Fabio Midulla
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome
Email: info@benthamscience.net
Список литературы
- Shi T, McAllister DA, OBrien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study. Lancet 2017; 390(10098): 946-58. doi: 10.1016/S0140-6736(17)30938-8 PMID: 28689664
- Nicolai A, Ferrara M, Schiavariello C, et al. Viral bronchiolitis in children: A common condition with few therapeutic options. Early Hum Dev 2013; 89(Suppl. 3): S7-S11. doi: 10.1016/j.earlhumdev.2013.07.016 PMID: 23972293
- Sander B, Finkelstein Y, Lu H, et al. Healthcare cost attributable to bronchiolitis: A population-based cohort study. PLoS One 2021; 16(12): e0260809. doi: 10.1371/journal.pone.0260809 PMID: 34855892
- Vandini S, Biagi C, Lanari M. Respiratory syncytial virus: The influence of serotype and genotype variability on clinical course of infection. Int J Mol Sci 2017; 18(8): 1717. doi: 10.3390/ijms18081717 PMID: 28783078
- Silver AH, Nazif JM. Bronchiolitis. Pediatr Rev 2019; 40(11): 568-76. doi: 10.1542/pir.2018-0260 PMID: 31676530
- Bohmwald K, Espinoza J, Rey-Jurado E, et al. Human respiratory syncytial virus: Infection and pathology. Semin Respir Crit Care Med 2016; 37(4): 522-37. doi: 10.1055/s-0036-1584799 PMID: 27486734
- García CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 2010; 126(6): e1453-60. doi: 10.1542/peds.2010-0507 PMID: 21098154
- Milani GP, Bollati V, Ruggiero L, et al. Bronchiolitis and SARS-CoV-2. Arch Dis Child 2021; 106(10): 999-1001. doi: 10.1136/archdischild-2020-321108 PMID: 33707224
- Andina-Martinez D, Alonso-Cadenas JA, Cobos-Carrascosa E, et al. SARS-CoV-2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe. Pediatr Pulmonol 2022; 57(1): 57-65. doi: 10.1002/ppul.25731 PMID: 34664782
- Flores-Pérez P, Gerig N, Cabrera-López MI, de Unzueta-Roch JL, del Rosal T, Calvo C. Acute bronchiolitis during the COVID-19 pandemic. Enferm Infecc Microbiol Clin 2022; 40(10): 572-5. doi: 10.1016/j.eimc.2021.06.012 PMID: 34219854
- Petrarca L, Nenna R, Frassanito A, et al. Acute bronchiolitis: Influence of viral co-infection in infants hospitalized over 12 consecutive epidemic seasons. J Med Virol 2018; 90(4): 631-8. doi: 10.1002/jmv.24994 PMID: 29226974
- Fretzayas A, Moustaki M. Etiology and clinical features of viral bronchiolitis in infancy. World J Pediatr 2017; 13(4): 293-9. doi: 10.1007/s12519-017-0031-8 PMID: 28470580
- Janet S, Broad J, Snape MD. Respiratory syncytial virus seasonality and its implications on prevention strategies. Hum Vaccin Immunother 2018; 14(1): 234-44. doi: 10.1080/21645515.2017.1403707 PMID: 29194014
- Barbati F, Moriondo M, Pisano L, et al. Epidemiology of respiratory syncytial virus-related hospitalization over a 5-year period in italy: Evaluation of seasonality and age distribution before vaccine Introduction. Vaccines 2020; 8(1): 15. doi: 10.3390/vaccines8010015 PMID: 31947976
- Van Brusselen D, De Troeyer K, ter Haar E, et al. Bronchiolitis in COVID-19 times: A nearly absent disease? Eur J Pediatr 2021; 180(6): 1969-73. doi: 10.1007/s00431-021-03968-6 PMID: 33517482
- Jiang X, Wang T, Dai G, et al. Clinical characteristics and etiology of children with bronchiolitis before and during the COVID-19 pandemic in Suzhou, China. Front Pediatr 2022; 10: 974769. doi: 10.3389/fped.2022.974769 PMID: 36452360
- Nenna R, Matera L, Pierangeli A, et al. First COVID-19 lockdown resulted in most respiratory viruses disappearing among hospitalised children, with the exception of rhinoviruses. Acta Paediatr 2022; 111(7): 1399-403. doi: 10.1111/apa.16326 PMID: 35266576
- Foley DA, Yeoh DK, Minney-Smith CA, et al. The Interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of coronavirus disease 2019-related public health measures. Clin Infect Dis 2021; 73(9): e2829-30. doi: 10.1093/cid/ciaa1906 PMID: 33594407
- Bermúdez Barrezueta L, Gutiérrez Zamorano M, López-Casillas P, Brezmes-Raposo M, Sanz Fernández I, Pino Vázquez MA. Influence of the COVID-19 pandemic on the epidemiology of acute bronchiolitis. Enferm Infecc Microbiol Clin 2023; 41(6): 348-51.
- Gill PJ, Chanchlani N, Mahant S. Bronchiolitis. CMAJ 2022; 194(6): E216. doi: 10.1503/cmaj.211810 PMID: 35165133
- Guitart C, Bobillo-Perez S, Alejandre C, et al. Bronchiolitis, epidemiological changes during the SARS-CoV-2 pandemic. BMC Infect Dis 2022; 22(1): 84. doi: 10.1186/s12879-022-07041-x PMID: 35073855
- Fan R, Wen B, Liu W, et al. Altered regulatory cytokine profiles in cases of pediatric respiratory syncytial virus infection. Cytokine 2018; 103: 57-62. doi: 10.1016/j.cyto.2017.12.028 PMID: 29324262
- Sebina I, Phipps S. The contribution of neutrophils to the pathogenesis of RSV bronchiolitis. Viruses 2020; 12(8): 808. doi: 10.3390/v12080808 PMID: 32726921
- Dalziel SR, Haskell L, OBrien S, et al. Bronchiolitis. Lancet 2022; 400(10349): 392-406. doi: 10.1016/S0140-6736(22)01016-9 PMID: 35785792
- Eber E, Midulla F. ERS Handbook of Paediatric Respiratory Medicine. (2nd ed..), European Respiratory Society 2021. doi: 10.1183/9781849841313.eph01
- Mitri EJ, Zheng DX, Garg V, et al. Blood eosinophils, specific immunoglobulin E, and bronchiolitis severity. Pediatr Pulmonol 2021; 56(9): 2997-3004. doi: 10.1002/ppul.25543 PMID: 34156171
- Raita Y, Pérez-Losada M, Freishtat RJ, et al. Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma. Nat Commun 2021; 12(1): 3601. doi: 10.1038/s41467-021-23859-6 PMID: 34127671
- Jartti T, Smits HH, Bønnelykke K, et al. Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy 2019; 74(1): 40-52. doi: 10.1111/all.13624 PMID: 30276826
- Dumas O, Mansbach JM, Jartti T, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax 2016; 71(8): 712-8. doi: 10.1136/thoraxjnl-2016-208535 PMID: 27339060
- Cangiano G, Nenna R, Frassanito A, et al. Bronchiolitis: Analysis of 10 consecutive epidemic seasons. Pediatr Pulmonol 2016; 51(12): 1330-5. doi: 10.1002/ppul.23476 PMID: 27228123
- Petrarca L, Nenna R, Di Mattia G, et al. Bronchiolitis phenotypes identified by latent class analysis may influence the occurrence of respiratory sequelae. Pediatr Pulmonol 2022; 57(3): 616-22. doi: 10.1002/ppul.25799 PMID: 34931488
- Schroeder AR, Mansbach JM, Stevenson M, et al. Apnea in children hospitalized with bronchiolitis. Pediatrics 2013; 132(5): e1194-201. doi: 10.1542/peds.2013-1501 PMID: 24101759
- National Institute for Health and Care Excellence (NICE). Bronchiolitis in children: Diagnosis and management. 2021. Available from:https://www.nice.org.uk/guidance/ng9 (cited: Dec 18, 2022)
- Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet 2017; 389(10065): 211-24. doi: 10.1016/S0140-6736(16)30951-5 PMID: 27549684
- Mansbach JM, Clark S, Piedra PA, et al. Hospital course and discharge criteria for children hospitalized with bronchiolitis. J Hosp Med 2015; 10(4): 205-11. doi: 10.1002/jhm.2318 PMID: 25627657
- Hancock DG, Charles-Britton B, Dixon DL, Forsyth KD. The heterogeneity of viral bronchiolitis: A lack of universal consensus definitions. Pediatr Pulmonol 2017; 52(9): 1234-40. doi: 10.1002/ppul.23750 PMID: 28672069
- Rodriguez-Martinez CE, Sossa-Briceño MP, Nino G. Systematic review of instruments aimed at evaluating the severity of bronchiolitis. Paediatr Respir Rev 2018; 25: 43-57. PMID: 28258885
- Midulla F, Petrarca L, Frassanito A, Di Mattia G, Zicari AM, Nenna R. Bronchiolitis clinics and medical treatment. Minerva Pediatr 2018; 70(6): 600-11. doi: 10.23736/S0026-4946.18.05334-3 PMID: 30334624
- Friedman JN, Davis T, Somaskanthan A, Ma A. Avoid doing chest x rays in infants with typical bronchiolitis. BMJ 2021; 375: e064132. doi: 10.1136/bmj-2021-064132 PMID: 34686495
- Sarmiento L, Rojas-Soto GE, Rodríguez-Martínez CE. Predictors of inappropriate use of diagnostic tests and management of bronchiolitis. BioMed Res Int 2017; 2017: 1-6. doi: 10.1155/2017/9730696 PMID: 28758127
- Supino MC, Buonsenso D, Scateni S, et al. Point-of-care lung ultrasound in infants with bronchiolitis in the pediatric emergency department: A prospective study. Eur J Pediatr 2019; 178(5): 623-32. doi: 10.1007/s00431-019-03335-6 PMID: 30747262
- La Regina DP, Bloise S, Pepino D, et al. Lung ultrasound in bronchiolitis. Pediatr Pulmonol 2021; 56(1): 234-9. doi: 10.1002/ppul.25156 PMID: 33151023
- Stollar F, Alcoba G, Gervaix A, Argiroffo CB. Virologic testing in bronchiolitis: Does it change management decisions and predict outcomes? Eur J Pediatr 2014; 173(11): 1429-35. doi: 10.1007/s00431-014-2334-2 PMID: 24858463
- Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial infection in children hospitalized with bronchiolitis. Hosp Pediatr 2014; 4(1): 33-8. doi: 10.1542/hpeds.2013-0073 PMID: 24435599
- McDaniel CE, Ralston S, Lucas B, Schroeder AR. Association of diagnostic criteria with urinary tract infection prevalence in bronchiolitis. JAMA Pediatr 2019; 173(3): 269-77. doi: 10.1001/jamapediatrics.2018.5091 PMID: 30688987
- Mahant S, Wahi G, Bayliss A, et al. Intermittent vs continuous pulse oximetry in hospitalized infants with stabilized bronchiolitis. JAMA Pediatr 2021; 175(5): 466-74. doi: 10.1001/jamapediatrics.2020.6141 PMID: 33646286
- Nagakumar P, Doull I. Current therapy for bronchiolitis. Arch Dis Child 2012; 97(9): 827-30. doi: 10.1136/archdischild-2011-301579 PMID: 22734014
- Oakley E, Borland M, Neutze J, et al. Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: A randomised trial. Lancet Respir Med 2013; 1(2): 113-20. doi: 10.1016/S2213-2600(12)70053-X PMID: 24429091
- Oakley E, Bata S, Rengasamy S, et al. Nasogastric hydration in infants with bronchiolitis less than 2 months of age. J Pediatr 2016; 178: 241-245.e1. doi: 10.1016/j.jpeds.2016.07.012 PMID: 27522439
- Van Ginderdeuren F, Vandenplas Y, Deneyer M, Vanlaethem S, Buyl R, Kerckhofs E. Effectiveness of airway clearance techniques in children hospitalized with acute bronchiolitis. Pediatr Pulmonol 2017; 52(2): 225-31. doi: 10.1002/ppul.23495 PMID: 27254132
- Cunningham S, Rodriguez A, Adams T, et al. Oxygen saturation targets in infants with bronchiolitis (BIDS): A double-blind, randomised, equivalence trial. Lancet 2015; 386(9998): 1041-8. doi: 10.1016/S0140-6736(15)00163-4 PMID: 26382998
- Lin J, Zhang Y, Xiong L, Liu S, Gong C, Dai J. High-flow nasal cannula therapy for children with bronchiolitis: A systematic review and meta-analysis. Arch Dis Child 2019; 104(6): 564-76. doi: 10.1136/archdischild-2018-315846 PMID: 30655267
- OBrien S, Craig S, Babl FE, Borland ML, Oakley E, Dalziel SR. Rational use of high-flow therapy in infants with bronchiolitis. What do the latest trials tell us? A paediatric research in emergency departments international collaborative perspective. J Paediatr Child Health 2019; 55(7): 746-52. doi: 10.1111/jpc.14496 PMID: 31270867
- Durand P, Guiddir T, Kyheng C, et al. A randomised trial of high-flow nasal cannula in infants with moderate bronchiolitis. Eur Respir J 2020; 56(1): 1901926. doi: 10.1183/13993003.01926-2019 PMID: 32381496
- Kepreotes E, Whitehead B, Attia J, et al. High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): An open, phase 4, randomised controlled trial. Lancet 2017; 389(10072): 930-9. doi: 10.1016/S0140-6736(17)30061-2 PMID: 28161016
- Ralston SL. High-flow nasal cannula therapy for pediatric patients with bronchiolitis. JAMA Pediatr 2020; 174(7): 635-6. doi: 10.1001/jamapediatrics.2020.0040 PMID: 32202628
- Dafydd C, Saunders BJ, Kotecha SJ, Edwards MO. Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: Systematic review and meta-analysis. BMJ Open Respir Res 2021; 8(1): e000844. doi: 10.1136/bmjresp-2020-000844 PMID: 34326153
- Tortosa F, Izcovich A, Carrasco G, Varone G, Haluska P, Sanguine V. High-flow oxygen nasal cannula for treating acute bronchiolitis in infants: A systematic review and meta-analysis. Medwave 2021; 21(4): e8190. doi: 10.5867/medwave.2021.04.8190 PMID: 34086669
- Lipshaw MJ, Florin TA. "Dont Just Do Something, Stand There": Embracing deimplementation of bronchiolitis therapeutics. Pediatrics 2021; 147(5): e2020048645. doi: 10.1542/peds.2020-048645 PMID: 33893228
- Elliott SA, Gaudet LA, Fernandes RM, et al. Comparative efficacy of bronchiolitis interventions in acute care: A network meta-analysis. Pediatrics 2021; 147(5): e2020040816. doi: 10.1542/peds.2020-040816 PMID: 33893229
- Nordal EB, Granslo HN, Esaiassen E, Leknessund CBB, Forsdahl BA. Bronchiolitis should not be treated with glucocorticoids or antibiotics. Tidsskr Nor Laegeforen 2021; 141(2) doi: 10.4045/tidsskr.21.0862 PMID: 35107946
- Heikkilä P, Korppi M. Hypertonic saline in bronchiolitis: An updated meta-analysis. Arch Dis Child 2021; 106(1): 102.2-. doi: 10.1136/archdischild-2020-319048 PMID: 32213483
- Plint AC, Johnson DW, Patel H, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009; 360(20): 2079-89. doi: 10.1056/NEJMoa0900544 PMID: 19439742
- Manti S, Staiano A, Orfeo L, et al. UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr 2023; 49(1): 19. doi: 10.1186/s13052-022-01392-6 PMID: 36765418
- Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2014; 2014(6): CD001266. PMID: 24937099
- Chung A, Reeves RM, Nair H, et al. Hospital admission trends for bronchiolitis in Scotland, 2001-2016: A national retrospective observational study. J Infect Dis 2020; 222(Suppl. 7): S592-8. doi: 10.1093/infdis/jiaa323 PMID: 32794556
- Hasegawa K, Mansbach JM, Ajami NJ, et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J 2016; 48(5): 1329-39. doi: 10.1183/13993003.00152-2016 PMID: 27799386
- Norlander AE, Peebles RS Jr. Innate type 2 responses to respiratory syncytial virus infection. Viruses 2020; 12(5): 521. doi: 10.3390/v12050521 PMID: 32397226
- Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013; 368(19): 1791-9. doi: 10.1056/NEJMoa1211917 PMID: 23656644
- Brunwasser SM, Snyder BM, Driscoll AJ, et al. Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: A systematic review and meta-analysis. Lancet Respir Med 2020; 8(8): 795-806. doi: 10.1016/S2213-2600(20)30109-0 PMID: 32763206
- Midulla F, Nicolai A, Ferrara M, et al. Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia. Acta Paediatr 2014; 103(10): 1094-9. doi: 10.1111/apa.12720 PMID: 24948158
- Wang G, Han D, Jiang Z, Li M, Yang S, Liu L. Association between early bronchiolitis and the development of childhood asthma: A meta-analysis. BMJ Open 2021; 11(5): e043956. doi: 10.1136/bmjopen-2020-043956 PMID: 34049905
- Mooney K, Melvin M, Douglas T. Ribavirin: The need for exposure precautions. Clin J Oncol Nurs 2014; 18(5): E93-6. doi: 10.1188/14.CJON.E93-E96 PMID: 25253120
- Noor A, Krilov LR. Respiratory syncytial virus vaccine: Where are we now and what comes next? Expert Opin Biol Ther 2018; 18(12): 1247-56. doi: 10.1080/14712598.2018.1544239 PMID: 30426788
- Brady MT, Byington CL, Davies HD, et al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134(2): e620-38. doi: 10.1542/peds.2014-1666 PMID: 25070304
- Garegnani L, Styrmisdóttir L, Roson Rodriguez P, Escobar Liquitay CM, Esteban I, Franco JV. Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database Syst Rev 2021; 11(11): CD013757. PMID: 34783356
- Gonzales T, Bergamasco A, Cristarella T, et al. Effectiveness and safety of palivizumab for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus: A systematic review. Am J Perinatol 2023. doi: 10.1055/a-1990-2633 PMID: 36452969
- Zhu Q, McLellan JS, Kallewaard NL, et al. A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med 2017; 9(388): eaaj1928. doi: 10.1126/scitranslmed.aaj1928
- Griffin MP, Yuan Y, Takas T, et al. Single-dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med 2020; 383(5): 415-25. doi: 10.1056/NEJMoa1913556 PMID: 32726528
- Hammitt LL, Dagan R, Yuan Y, et al. Nirsevimab for prevention of RSV in healthy late-preterm and term infants. N Engl J Med 2022; 386(9): 837-46. doi: 10.1056/NEJMoa2110275 PMID: 35235726
- Maas BM, Lommerse J, Plock N, et al. Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis. EBioMedicine 2021; 73: 103651. doi: 10.1016/j.ebiom.2021.103651 PMID: 34775220
- Mazur NI, Terstappen J, Baral R, et al. Respiratory syncytial virus prevention within reach: The vaccine and monoclonal antibody landscape. Lancet Infect Dis 2023; 23(1): e2-e21. doi: 10.1016/S1473-3099(22)00291-2 PMID: 35952703
- Aranda SS, Polack FP. Prevention of pediatric respiratory syncytial virus lower respiratory tract illness: perspectives for the next decade. Front Immunol 2019; 10: 1006. doi: 10.3389/fimmu.2019.01006 PMID: 31134078
- Smith TRF, Schultheis K, Broderick KE. Nucleic acid-based vaccines targeting respiratory syncytial virus: Delivering the goods. Hum Vaccin Immunother 2017; 13(11): 2626-9. doi: 10.1080/21645515.2017.1363134 PMID: 28881156
- Scheltema NM, Kavelaars XM, Thorburn K, et al. Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy. Vaccine 2018; 36(31): 4693-700. doi: 10.1016/j.vaccine.2018.06.021 PMID: 29941327
- Pfizer Inc. Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate. 2022. Available from:https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-top-line-data-phase-3-global (cited: Dec 18, 2022)
- Achten NB, Wu P, Bont L, et al. Interference between respiratory syncytial virus and human rhinovirus infection in infancy. J Infect Dis 2017; 215(7): 1102-6. doi: 10.1093/infdis/jix031 PMID: 28368456
Дополнительные файлы
